ClinicalTrials.Veeva

Menu

Phosphorous Magnetic Resonance Spectroscopy of Heart

The Washington University logo

The Washington University

Status

Completed

Conditions

Left Ventricular Dysfunction

Treatments

Diagnostic Test: MR Spectroscopy

Study type

Interventional

Funder types

Other

Identifiers

NCT01110395
09-0533

Details and patient eligibility

About

Heart needs constant supply of energy to continue working. Phosphorus magnetic resonance spectroscopy allows us to measure energy produced in the heart. The purpose of this study is to determine if the energy production is reduced in failing heart.

Full description

We will use non-invasive phosphorus magnetic resonance spectroscopy technique to measure creatine kinase (CK) flux in failing heart. The studies will be done on Siemens 3.0T human system. We will recruit subjects with LV dysfunction due to prior anterior wall myocardial infarction.

Enrollment

15 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Individuals with left ventricular dysfunction

Exclusion criteria

  • Age < 18, pregnant, history of excessive alcohol use, or any condition (e.g. claustrophobia, a pacemaker) that would prevent him/her from completing the magnetic resonance spectroscopy study

Trial design

Primary purpose

Basic Science

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

15 participants in 1 patient group

MR Spectroscopy Post-Heart Transplant
Experimental group
Description:
Patients post heart transplant getting heart biopsy
Treatment:
Diagnostic Test: MR Spectroscopy

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems